Gemifloxacin mesylate is a synthetic broad spectrum fluoroquinolone antibiotic for oral administration. It is bactericidal with minimum bactericidal concentrations. Gemifloxacin acts by inhibiting DNA synthesis through inhibition of the bacterial type-II topoisomerases, DNA gyrase and/or topoisomerase IV (TOPO IV) which are both essential for bacterial growth.